MAPK8 and Parkinson disease: The mixed JNK inhibitor CEP1347, the vitamin coenzyme Q10 designed to promote mitochondrial aerobic respiration, the neuroimmunophylline GPI1845, and the glutamate release inhibitor riluzole have all failed to influence PD progression based on both clinical ratings and imaging measures.